| URL | https://bioprocessintl.com/bioprocess-insider/deal |
| Source | https://bioprocessintl.com |
| Date Published | 02/14/2022 |
| Author Name | Millie Nelson |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Resilience |
| Parent company | Ology Bioservices |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| City reshored to: | San Diego |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Monoclonal antibody |